Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Othera Pharmaceuticals logo — company profile

Othera Pharmaceuticals

Founded 2002 United States Exton, United States 27 employees Debt Financing Total: $23.62M Biotechnology, Health Care +1

General Information

Company Name Othera Pharmaceuticals
Founded Year 2002
Location United States Exton, United States +1
Employees 27
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Debt Financing
Social

Get notified when Othera Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Othera Pharmaceuticals

Othera Pharmaceuticals, founded in 2002, is a pharmaceutical company focused on advancing innovative therapeutics for age-related diseases of the eye. The company's flagship product, OT-551, is currently undergoing Phase II clinical trials for the dry form of macular degeneration (AMD). Notably, the company has revealed promising interim data from the trial and anticipates releasing full trial results by mid-2010. With headquarters in the United States, Othera is also dedicated to pioneering novel treatments for glaucoma and neurodegenerative diseases. As of 04 August 2009, the company secured a significant $10.62M debt financing investment, highlighting investor confidence in its pioneering approach to addressing critical unmet medical needs within the Biotechnology, Health Care, and Pharmaceutical industries.

Taxonomy: ophthalmic diseases, pharmaceutical company, dry AMD, biopharmaceuticals, drug development, clinical trials, neuroprotectant, glaucoma treatment, ophthalmology, OT-551, OT-730, OT-440

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 04 Aug 2009
Series B •••••• 3
Investor Investor
•••• •••• 		19 Aug 2004

Othera Pharmaceuticals Alternatives & Competitors

Othera Pharmaceuticals vs
ForSight VISION5 (now Allergan)
ForSight VISION5 (now Allergan)

ForSight VISION5 was acquired by Allergan in 2016.

Debt Financing
4 employees
Health Care, Pharmaceutical
Compare Othera Pharmaceuticals vs ForSight VISION5 (now Allergan)
Othera Pharmaceuticals vs
Topivert Pharma Limited
Topivert Pharma Limited United Kingdom

TopiVert is a clinical-stage biotechnology company developing next-generation, Narrow Spectrum Kinas...

Series A
3 employees
Biotechnology, Health Care
Compare Othera Pharmaceuticals vs Topivert Pharma Limited
Othera Pharmaceuticals vs
Allgenesis Biotherapeutics Inc.
Allgenesis Biotherapeutics Inc. Taiwan

We leverage our expertise to create an ophthalmic pipeline for unmet medical needs.

9 employees
Health Care, Health and Wellness
Also compare with: Othera Pharmaceuticals vs BBB Therapeutics BBB Therapeutics

FAQ About Othera Pharmaceuticals

Othera is a pharmaceutical company developing novel therapeutics for age-related diseases of the eye. Othera's lead compound, OT-551 is an eye drop in a Phase II clinical trial for the dry form of macular degeneration (AMD), and recently announced positive interim data from that trial, with full tri...
Othera Pharmaceuticals was founded in 2002.
Othera Pharmaceuticals is headquartered in Exton, United States.
Othera Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Othera Pharmaceuticals has approximately 27 employees.
Othera Pharmaceuticals has completed 2 funding rounds, raising a total of $23.62M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Othera Pharmaceuticals include ForSight VISION5 (now Allergan), Topivert Pharma Limited, Allgenesis Biotherapeutics Inc., BBB Therapeutics, Nevrargenics Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Othera Pharmaceuticals and ForSight VISION5 (now Allergan) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Othera Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes